Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Stanford, Epigenomics, Hologic, Life Tech, Others Win US Patents


Stanford University has been awarded US Patent No. 8,702,948, "Method and apparatus using electric field for improved biological assays."

Mostafa Ronaghi, Tarun Khurana, and Juan Santiago are named as inventors.

Epigenomics has been awarded US Patent No. 8,703,414, "Method for the quantification of methylated DNA."

Reimo Tetzner is named as the inventor.

Universidad del Pais Vasco has been awarded US Patent No. 8,703,420, "Methods and reagents for the detection of Salmonella spp."

Javier Candina, Aitor Ruiz, Joseba Bikandi, Fernando Otsoa, Ilargi Ballesteros, Fernando Aguirre, and Isabel De Galarreta are named as inventors.

Gen-Probe (Hologic) has been awarded US Patent No. 8,703,421, "Compositions, kits, and related methods for the detection and/or monitoring of Salmonella."

Michael Reshatoff, Edgar Ong, and James Hogan are named as inventors.

National University Corporation Shizuoka University has been awarded US Patent No. 8,703,423, "Method of detecting a functional filamentous fungus, method of evaluating a product containing a functional filamentous fungus, and primer pair."

Kiyohiko Nakasaki is named as the inventor.

Abbott Point of Care have been awarded US Patent No. 8,703,445, "Molecular diagnostics amplification system and methods."

Gordon Collier, Jason MacLeod, Attila Nemeth, and William Dicke are named as inventors.

Biocartis has been awarded US Patent No. 8,703,476, "Cartridge for automated medical diagnostics."

Ronald De Gier, Danny Schaefer, AdrianusVan Den Bijgaart, Chris Van Haag, and Michiel De Jong are named as inventors.

Applied Biosystems (Thermo Fisher Scientific) has been awarded US Patent No. 8,703,497, "Nanowire-based system for analysis of nucleic acids."

Hongye Sun, Steven Fung, and Sam Woo are named as inventors.

Kimberly-Clark has been awarded US Patent No. 8,703,504, "Membrane-based lateral flow assay devices that utilize phosphorescent detection."

Xuedong Song is named as the inventor.

NVS Technologies has been awarded US Patent No. 8,703,653, "Quantitative, highly multiplexed detection of nucleic acids."

Kris Scaboo, Patrick Martin, Brad Taft, and Jason La are named as inventors.

Life Technologies (Thermo Fisher Scientific) has been awarded US Patent No. 8,703,925, "Chemically-enhanced primer compositions, methods, and kits."

Linda Lee, Sam Woo, and Peter Ma are named as inventors.

Cornell Research Foundation has been awarded US Patent No. 8,703,928, "Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays."

Francis Barany, George Barany, Robert Hammer, Maria Kempe, Herman Blok, and Monib Zirvi are named as inventors.

Siemens Healthcare Diagnostics has been awarded US Patent No. 8,703,931, "Method for purification of nucleic acids, particularly from fixed tissue."

Heike Euting, Guido Hennig, Alexandre Izmailov are named as inventors.

The Chinese University of Hong Kong has been awarded US Patent No. 8,706,422, "Determining a nucleic acid sequence imbalance."

Yuk-Ming Lo, Rossa Chiu, Kwan Chan, Benny Zee, and Ka Chong are named as inventors.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.